Three Top Obesity Treatment Stocks to Buy and Hold Today

June 5, 2024 www.tradewins.com Other Exciting News Fear of Losing vs. Fear of Missing Out What a dilemma… So, why not just do what I do? 23 Profitable Years In A Row… Here’s My Secret My name’s Chuck Hughes. And as a 38-year trading professional and 10-time trading champion, there are 2 things I can say with absolute authority… 1. Not every trade will be a winner… 2. But, if you copy my secret it is definitely possible to make every year a winner! If you take into account every trade I recommended over the past 23 years, the average closed trade profit opportunity is 165.7%.... with no major drawdowns. Click Here to discover the simple formula responsible for my trade signals producing 23 years of monumental profit opportunities without a single losing year. Best Regards, Chuck Hughes Recent Articles Three Top Obesity Treatment Stocks to Buy and Hold Today by Ian Cooper Volatility Skews: The Technical Side by Dave Caplan Top That Trade Weekly Update by Alan Knuckman TradeWins Author Team     Unlock the 30-day secret to potentially making an extra $1,403 per month with a tiny account! In fact, You could’ve made a total of 742% on your money doing exactly this the past 5 years (includes winners and losers). What if you could make an extra $1,403 every 30 days? You’re not getting rich, per se… But you’re generating some extra cash to have and spend during these unprecedented economic times. Now, that $1,403 isn’t a promise… it’s simply an average. As you’re about to see… with many opportunities, you could’ve had months where you turned a few hundred bucks into thousands and thousands. You don’t need any special skills. Just patience and trust in a system that’s worked for years. My system. Join Trade Alert 365 Now For Just $1 About TradeWins Inside Trading Newsletter Webinars Videos Trading Strategy Options Futures Forex Day Trading Subscription Services E-Books Customer Satisfaction Survey 2020 Three Top Obesity Treatment Stocks to Buy and Hold Today by Ian Cooper With growing interest in obesity treatments, Goldman Sachs just raised its market estimates from $100 billion to $130 billion. “The estimate was revised as the firm projects the number of Americans on anti-obesity drugs could reach ~19M by 2030, up from its previous estimate of ~15M. This indicates a ~17% market penetration among U.S. adults,” as noted by Seeking Alpha. While that’s certainly great news for obesity treatment heavyweights like Eli Lilly (LLY) and Novo Nordisk (NVO), it’s also fueling momentum in up-and-coming treatment stocks, like: Viking Therapeutics (VKTX) With Viking Therapeutics, the company is seeing good success with its GLP-1 obesity drug trials. It already reported that its Phase 2 VENTURE trial successfully achieved is primary endpoint and all secondary endpoints. It also said patients receiving VK-2735 demonstrated weight loss after 13 weeks, rating up to 14.7% from baseline weight. Better, VKTX is about to start Phase 2 trials of its once-a-day weight loss pill. Viking said patients who received the pill once a day lost up to 5.3% of their weight on average, or up to 3.3% more than those who took a placebo, at 28 days, as noted by CNBC. Altimmune (ALT) The company’s pemvidutide treatment led to weight loss while preserving lean mass, as noted in trial data. In addition, data from a 48-week trial showed that about 74.5% of weight loss was linked to fat tissue. About 25.5% was linked to lean mass, which may give it a leg up against the competition. “We believe that pemvidutide has the potential to distinguish itself broadly from other therapies for the treatment of obesity,” ALT CEO Vipin Garg added. Read More   Volatility Skews: The Technical Side by Dave Caplan The volatility makeup for a particular market is referred to in the industry as the skew. Each commodity, or group of commodities, has their own particular skew. In many markets a skew exists, meaning that the out-of-the-money calls/puts trade at a higher volatility than the at-the-money options. Some markets have a normal skew, which if you graphically plotted the implied volatilities the picture would be a “V”. This occurs because the out-of-the-money options “vega” is so low, therefore a percentage point increase in volatility in these options equates to a small price change. Other markets have a skew to only one side or the other, meaning the further you go out-of-the-money in either the calls or the puts, the higher the implied volatility of those strikes is. In reality, volatility skews have three basic configurations. The “normal” configuration is “U” shaped. The strikes more distant from the at-the-money strike trade at higher volatility; the at-the-money having the lowest implied. If one was to plot out the different volatilities, and connect the dots, the formation would be that of a “U”. The reason that this phenomenon exists ties in with the properties of vega. The vega decreases as the strike price moves further from being at-the-money. The sensitivity to volatility changes decrease as the strike moves away from being at-the-money. Deep in-the-money or out-of-the-money options have small vega. A volatility change will not affect the price of the option that much. Currency options commonly have this configuration. Read More Top That Trade Weekly Update by Alan Knuckman Here’s your chance to become a bonafide “Insider” at the wildly popular Top That Trade weekly debate… syndicated on more than 100 TV stations around the world. Being an “Insider” is not only fun and exciting… it’s empowering! As a valued Triple-T Insider, every Friday a Top That Trade Insider Briefing will be delivered to your inbox… With a direct link to the current Top That Trade episode and tantalizing insight you won’t find anywhere else… here are this week’s topics! 1) SUMMER STOCK DONE OR FUN? 2) BBQ SEASON SAVE STOCKS 3) ZERO to 80 RATE WORRIES Watch Video   www.tradewins.com                © Copyright 2024 TradeWins.com. All rights reserved. TradeWins Publishing, 22C New Leicester Hwy, #117, Asheville, NC 28806 Email: support@iss-trading.com   |   Phone: 888-233-1431   |   Fax: 888-258-4938   PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading. 1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis. 2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services. 3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber. 4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more. 5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities. 6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown. 7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses. 8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
TradeWins Publishing, 528 North Country Rd., St. James, NY 11780

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: